Inspire Advisors, LLC

13F Filings History

Latest 13F report
Q3 2025 - Oct 29, 2025
Value $
$1.05B
Signature - Title
Aaron Moon - Chief Compliance Officer/Investment Adviser Representative
Location
Meridian, ID
Summary
This page shows a list of all the recent 13F filings made by Inspire Advisors, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Inspire Advisors, LLC reported 528 stock holdings with total value $1.05B as of Q3 2025. Top holdings included WWJD, RISN, IBD, ISMD, and PTL.

Notify me when Inspire Advisors, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2025 528 $1.05B +$108M -$77.8M +$30M WWJD, RISN, IBD, ISMD, PTL 13F-HR 10/29/2025, 12:33 PM
Q2 2025 497 $964M +$194M -$138M +$55.7M WWJD, RISN, IBD, ISMD, PTL 13F-HR 8/11/2025, 03:32 PM
Q1 2025 449 $865M +$162M -$104M +$57.6M WWJD, IBD, RISN, ISMD, PTL 13F-HR 5/7/2025, 12:46 PM
Q4 2024 414 $817M +$81.1M -$66.6M +$14.6M WWJD, RISN, IBD, ISMD, PTL 13F-HR 2/7/2025, 04:42 PM
Q3 2024 423 $822M +$115M -$90.4M +$24.6M WWJD, RISN, IBD, ISMD, PTL 13F-HR 10/17/2024, 04:25 PM
Q2 2024 376 $754M +$208M -$163M +$45.2M IBD, WWJD, RISN, USFR, ISMD 13F-HR 8/8/2024, 04:23 PM
Q1 2024 371 $721M +$101M -$70.9M +$29.9M RISN, IBD, WWJD, BIBL, BLES 13F-HR 5/7/2024, 04:50 PM
Q4 2023 336 $665M +$142M -$89.3M +$52.5M RISN, IBD, WWJD, ISMD, BLES 13F-HR 2/12/2024, 02:46 PM
Q3 2023 279 $566M +$103M -$26.5M +$76.3M IBD, RISN, WWJD, USFR, BLES 13F-HR 10/26/2023, 11:48 AM
Q2 2023 245 $519M +$98.7M -$14.1M +$84.6M RISN, IBD, WWJD, BLES, USFR 13F-HR 7/31/2023, 10:20 AM
Q1 2023 203 $436M +$85.7M -$11.9M +$73.8M RISN, IBD, WWJD, USFR, BLES 13F-HR 4/24/2023, 10:24 AM
Q4 2022 185 $396M +$47.2M -$8.61M +$38.6M RISN, IBD, WWJD, BLES, BIBL 13F-HR 1/26/2023, 01:28 PM
Q3 2022 155 $364M +$69.5M -$21.8M +$47.7M RISN, IBD, BLES, WWJD, BIBL 13F-HR 11/7/2022, 03:56 PM
Q2 2022 117 $357M +$90.8M -$370K +$90.4M RISN, IBD, USFR, WWJD, BLES 13F-HR 8/10/2022, 09:11 AM
Q1 2022 112 $356M +$77.5M -$17.4M +$60.1M RISN, IBD, VGSH, BLES, WWJD 13F-HR 4/21/2022, 10:04 AM
Q4 2021 98 $327M +$48.1M -$7.99M +$40.1M RISN, IBD, ISMD, BLES, WWJD 13F-HR 2/2/2022, 04:32 PM
Q3 2021 91 $317M +$27.1M -$11.8M +$15.3M RISN, IBD, ISMD, WWJD, BLES 13F-HR 11/9/2021, 01:56 PM
Q2 2021 88 $307M +$30.8M -$16.8M +$14.1M RISN, ISMD, IBD, WWJD, BLES 13F-HR 8/10/2021, 04:53 PM
Q1 2021 77 $277M +$22.4M -$29.3M -$6.86M RISN, ISMD, IBD, WWJD, BLES 13F-HR 4/30/2021, 12:23 PM
Q4 2020 736 $268M RISN, ISMD, IBD, WWJD, BLES 13F-HR 2/12/2021, 01:47 PM